A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients

NCT05263869 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer With Liver Metastases

Interventions

DRUG: MRG002

Sponsor

Shanghai Miracogen Inc.